Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review synthesizing observational and meta-analytic evidence on drug–ICI interactions, offering clinical recommendations on statin, PPI, and corticosteroid use during checkpoint inhibitor therapy, but not reporting new primary data.
A mechanistic study identifying a metabolic pathway and proposing drug targets, but without clinical efficacy data, human trials, or validation of the proposed combination therapy.
Mechanistic study in cell culture identifying a putative regulatory axis; lacks clinical validation, patient outcomes, or prospective testing needed to support therapeutic claims.
A computational, exploratory bioinformatics study designed to generate hypotheses about lncRNA mechanisms in quercetin response, without experimental validation or causal evidence in breast cancer.
This is a narrative review integrating mechanistic concepts and emerging evidence rather than reporting original empirical findings or clinical outcomes; it raises questions about lipid metabolism as a therapeutic target rather than answering them with trial data.
A narrative review synthesizing mechanistic observations about shared metabolic pathways in cancer and SLE, proposing therapeutic hypotheses rather than reporting new empirical evidence or clinical outcomes.
This is a narrative review article that synthesizes existing evidence on drug repositioning concepts and mechanisms rather than reporting original empirical findings or clinical outcomes from a controlled study.